There is one clinical trial.
The aim of this unblinded parallel-group randomized multicenter clinical trial is to compare the clinical effectiveness of high flow nasal therapy (HFNT) with conventional oxygen therapy (COT) in patients with confirmed COVID-19 related acute hypoxemic respiratory failure.
Description: Proportion of patients needing escalation of treatment (i.e. noninvasive ventilation - including CPAP - or intubation).Measure: Proportion of patients needing escalation of treatment during hospital stay Time: 28 days
Description: Proportion of patients who receive continuous positive airway pressure during hospital stayMeasure: Proportion of patients who receive CPAP during hospital stay Time: 28 days
Description: Proportion of patients undergone noninvasive ventilation (e.g. BiLevel, PSV)Measure: Proportion of patients who receive NIV during hospital stay Time: 28 days
Description: Daily collection of Six simple physiological parameters that form the basis of the scoring system: respiration rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness or new confusion, temperature. A score is allocated to each parameter, with the magnitude of the score reflecting how extremely the parameter varies from the norm. The score is then aggregated and uplifted by 2 points for people requiring supplemental oxygen to maintain their recommended oxygen saturation. Range of values: 0 (best) - 23 (worst) points.Measure: National Early Warning Score 2 (NEWS2) during hospital stay Time: 28 days
Description: [0= no dyspnea to 10= severe dyspnea] - daily collectionMeasure: Dyspnea score (BORG scale) during hospital stay Time: 28 days
Description: SpO2/FiO2/Respiratory rate - daily collectionMeasure: ROX index during hospital stay Time: 28 days
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports